COMMERCIAL INFLUENCE IN HEALTH: FROM TRANSPARENCY TO INDEPENDENCE Pathways to independence: towards producing and using trustworthy evidence

被引：69

作者：

Moynihan, Ray ^{[1
]}

Bero, Lisa ^{[2
,3
]}

Hill, Sue ^{[4
]}

Johansson, Minna ^{[5
]}

Lexchin, Joel ^{[6
]}

Macdonald, Helen ^{[7
]}

Mintzes, Barbara ^{[2
,3
]}

Pearson, Cynthia ^{[8
]}

Rodwin, Marc A. ^{[9
]}

Stavdal, Anna ^{[10
]}

Stegenga, Jacob ^{[11
]}

Thombs, Brett D. ^{[12
,13
]}

Thornton, Hazel ^{[14
]}

Vandvik, Per Olav ^{[15
]}

Wieseler, Beate ^{[16
]}

Godlee, Fiona ^{[7
]}

机构：

[1] Bond Univ, Inst Evidence Based Healthcare, Gold Coast, Qld, Australia

[2] Univ Sydney, Sch Pharm, Camperdown, NSW, Australia

[3] Univ Sydney, Charles Perkins Ctr, Fac Med & Hlth, Camperdown, NSW, Australia

[4] World Hlth Org, Sci Div, Geneva, Switzerland

[5] Cochrane Sustainable Healthcare, Lund, Sweden

[6] York Univ, Sch Hlth Policy & Management, Toronto, ON, Canada

[7] BMJ, London, England

[8] Natl Womens Hlth Network, Washington, DC USA

[9] Suffolk Univ, Sch Law, Boston, MA 02114 USA

[10] Wonca World, Oslo, Norway

[11] Univ Cambridge, Dept Hist & Philosophy Sci, Cambridge, England

[12] Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ, Canada

[13] McGill Univ, Montreal, PQ, Canada

[14] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England

[15] Innlandet Hosp Trust, Dept Med, Gjovik, Norway

[16] Inst Qual & Efficiency Hlth Care IQWiG, Drug Assessment, Cologne, Germany

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2019年 / 367卷

基金：

加拿大健康研究院; 英国医学研究理事会;

关键词：

D O I：

10.1136/bmj.l6576

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页数：5

共 46 条

[1] Financial ties of principal investigators and randomized controlled trial outcomes: cross sectional study [J].

Ahn, Rosa ;

Woodbridge, Alexandra ;

Abraham, Ann ;

Saba, Susan ;

Korenstein, Deborah ;

Madden, Erin ;

Boscardin, W. John ;

Keyhani, Salomeh .

BMJ-BRITISH MEDICAL JOURNAL, 2017, 356

[2]

[Anonymous], 2018, PRESCRIPTION POVERTY

[3]

[Anonymous], 2016, BMJ BRIT MED J, DOI DOI 10.1136/BMJ.I5191

[4]

[Anonymous], 2006, PLOS MED, V3, pe329, DOI [10.1371/journal.pmed.003032917149970, DOI 10.1371/JOURNAL.PMED.003032917149970]

[5] Evidence for overuse of medical services around the world [J].

Brownlee, Shannon ;

Chalkidou, Kalipso ;

Doust, Jenny ;

Elshaug, Adam G. ;

Glasziou, Paul ;

Heath, Iona ;

Nagpal, Somil ;

Saini, Vikas ;

Srivastava, Divya ;

Chalmers, Kelsey ;

Korenstein, Deborah .

LANCET, 2017, 390 (10090) :156-168

[6] Financial Relationships between Organizations That Produce Clinical Practice Guidelines and the Biomedical Industry: A Cross-Sectional Study [J].

Campsall, Paul ;

Colizza, Kate ;

Straus, Sharon ;

Stelfox, Henry T. .

PLOS MEDICINE, 2016, 13 (05)

[7] Speed, Safety, and Industry Funding - From PDUFA I to PDUFA VI [J].

Darrow, Jonathan J. ;

Avorn, Jerry ;

Kesselheim, Aaron S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (23) :2278-2286

[8] Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries [J].

DeJong, Colette ;

Aguilar, Thomas ;

Tseng, Chien-Wen ;

Lin, Grace A. ;

Boscardin, W. John ;

Dudley, R. Adams .

JAMA INTERNAL MEDICINE, 2016, 176 (08) :1114-1122

[9]

Drugs for Neglected Diseases initiative, 2019, 15 YEARS NEEDS DRIV

[10]

Epstein RJ, 2010, Forbes

← 1 2 3 4 5 →